Acta Neuropathologica

, Volume 115, Issue 3, pp 345–356 | Cite as

CNS T-cell lymphoma: an under-recognized entity?

  • Mohanpal Singh Dulai
  • Christopher Y. Park
  • William D. Howell
  • Lawrence T. Smyth
  • Mayuri Desai
  • Diane M. Carter
  • Hannes Vogel
Original Paper

Abstract

The incidence of CNS lymphoma has increased significantly in the past 30 years, primarily in the elderly and immunocompromised. While T-cell lymphomas comprise 15–20% of systemic lymphomas, they comprise less than 4% of primary CNS lymphomas, suggesting that they may be under-recognized compared to their systemic counterparts. To investigate this, we studied brain biopsies from three patients who were diagnosed with T-cell lymphoma confined to the brain. They had enhancing lesions by MRI, arising in the cerebellum and brainstem in one and temporal lobe in two. We compared these to biopsies from three patients who had reactive lymphoid infiltrates and who had clinical signs/symptoms and radiographic findings that were indistinguishable from the lymphoma group. Biopsies from both the lymphoma group and reactive group showed considerable cytomorphologic heterogeneity. Although one lymphoma case contained large atypical cells, the other two contained small, mature lymphocytes within a heterogeneous infiltrate of neoplastic and reactive inflammatory cells. Surface marker aberrancies were present in two lymphoma cases, but this alone could not reliably diagnose T-cell lymphoma. The proliferation index was not useful for differentiating lymphoma from reactive infiltrates. In five of the six cases the diagnosis was most influenced by clonality studies for T-cell receptor-gamma gene rearrangements. We conclude that because of the high degree of overlap in cytomorphologic and immunophenotypic features between T-cell lymphoma and reactive infiltrates, T-cell lymphoma may not be recognized unless studies for T-cell receptor gene rearrangements are performed for CNS lesions composed of a polymorphous but predominantly T-cell infiltrate.

Keywords

T-cell lymphoma Primary CNS lymphoma T-cell receptor rearrangement Monoclonal T-cell Reactive lymphoid infiltrate 

Supplementary material

401_2007_338_MOESM1_ESM.tif (558 kb)
(TIF 557 kb)
401_2007_338_MOESM2_ESM.tif (560 kb)
(TIF 560 kb)
401_2007_338_MOESM3_ESM.tif (549 kb)
(TIF 548 kb)
401_2007_338_MOESM4_ESM.tif (538 kb)
(TIF 537 kb)

References

  1. 1.
    Alessi E, Coggi A, Venegoni L, Merlo V, Gianotti R (2005) The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma. Br J Dermatol 153:368–371PubMedCrossRefGoogle Scholar
  2. 2.
    Arber DA, Braziel RM, Bagg A, Bijwaard KE (2001) Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn 3:133–140PubMedGoogle Scholar
  3. 3.
    Bruggemann M, White H, Gaulard P, Garcia-Sanz R, Gameiro P, Oeschger S, Jasani B, Ott M, Delsol G, Orfao A, Tiemann M, Herbst H, Langerak AW, Spaargaren M, Moreau E, Groenen PJ, Sambade C, Foroni L, Carter GI, Hummel M, Bastard C, Davi F, Delfau-Larue MH, Kneba M, van Dongen JJ, Beldjord K, Molina TJ (2007) Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 concerted action BHM4 CT98–3936. Leukemia 21:215–221PubMedCrossRefGoogle Scholar
  4. 4.
    Burger PC, Scheithauer BW (1994) Primary central nervous system lymphoma. In: Atlas of tumor pathology: tumors of the central nervous system. Armed Forces Institute of Pathology, Washington, pp 321–327Google Scholar
  5. 5.
    Caproni M, Torchia D, Cardinali C, Volpi W, Del Bianco E, D’Agata A, Fabbri P (2004) Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 151:784–791PubMedCrossRefGoogle Scholar
  6. 6.
    Chandan VS, Schelper RL, Shrimpton A, Hutchison RE, Chang HT (2006) A 33-year-old man with multiple ring-enhancing lesions in the brain. Neuropathology 26:94–97PubMedCrossRefGoogle Scholar
  7. 7.
    Choi JS, Nam DH, Ko YH, Seo JW, Choi YL, Suh YL, Ree HJ (2003) Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 27:919–928PubMedCrossRefGoogle Scholar
  8. 8.
    Choi YL, Suh YL, Kim D, Ko YH, Sung CO, Lee JI (2006) Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy. Clin Neuropathol 25:29–36PubMedGoogle Scholar
  9. 9.
    Cooper PB, Auerbach A, Aguilera NS, Adair C, Moores L, Geyer D, Rushing EJ (2006) Rare primary CNS anaplastic large cell lymphoma in an immunocompetent adult: a clinical-pathologic case report and review case of the literature. Clin Neuropathol 25:232–236PubMedGoogle Scholar
  10. 10.
    Dias-Silva JJ, Maestre A, Diaz-Valino J, Lopez-Facal S (1997) Primary cerebral lymphoma of T phenotype in an immunocompetent patient. Rev Neurol 25:550–552PubMedGoogle Scholar
  11. 11.
    Dimitri D, Benveniste O, Dubourg O, Maisonobe T, Eymard B, Amoura Z, Jean L, Tiev K, Piette JC, Klatzmann D, Herson S, Boyer O (2006) Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain 129:986–995PubMedCrossRefGoogle Scholar
  12. 12.
    Diss TC, Watts M, Pan LX, Burke M, Linch D, Isaacson PG (1995) The polymerase chain reaction in the demonstration of monoclonality in T cell lymphomas. J Clin Pathol 48:1045–1050PubMedCrossRefGoogle Scholar
  13. 13.
    Doisne JM, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, Chaix ML, Sinet M, Venet A (2004) CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 173:2410–2418PubMedGoogle Scholar
  14. 14.
    Dokouhaki P, Razavi A, Moghaddam R, Akbariasbagh F, Ghaffari Novin M, Zarnani A, Jeddi Tehrani M (2005) Oligoclonal expression of T-cell receptor Beta variable genes in normal human endometrium. Iran J Allergy Asthma Immunol 4:67–76PubMedGoogle Scholar
  15. 15.
    Dungerwalla M, Osuji N, Waldman AD, Al Jehani F, Mehta A, Tailor R, Wotherspoon A, Cogill G, Matutes E (2005) Isolated central nervous system involvement in adult T-cell lymphoma/leukaemia. Br J Haematol 130:511–515PubMedCrossRefGoogle Scholar
  16. 16.
    Foucar K (2007) Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sezary syndrome. Am J Clin Pathol 127:496–510PubMedGoogle Scholar
  17. 17.
    George DH, Scheithauer BW, Aker FV, Kurtin PJ, Burger PC, Cameselle-Teijeiro J, McLendon RE, Parisi JE, Paulus W, Roggendorf W, Sotelo C (2003) Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression. Am J Surg Pathol 27:487–493PubMedCrossRefGoogle Scholar
  18. 18.
    Geppert M, Ostertag CB, Seitz G, Kiessling M (1990) Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol 80:629–634PubMedCrossRefGoogle Scholar
  19. 19.
    Gijtenbeek JM, Rosenblum MK, DeAngelis LM (2001) Primary central nervous system T-cell lymphoma. Neurology 57:716–718PubMedGoogle Scholar
  20. 20.
    Griesser H, Feller AC, Sterry W (1990) T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell-rich pseudolymphomas. J Invest Dermatol 95:292–295PubMedCrossRefGoogle Scholar
  21. 21.
    Harvell JD, Nowfar-Rad M, Sundram U (2003) An immunohistochemical study of CD4, CD8, TIA-1 and CD56 subsets in inflammatory skin disease. J Cutan Pathol 30:108–113PubMedCrossRefGoogle Scholar
  22. 22.
    Hochberg FH, Batchelor T (2003) Clinical and pathologic features of primary central nervous system lymphoma. UpToDate. http://patients.uptodate.com/topic.asp?file=lymphoma/12708
  23. 23.
    Hochberg FH, Baehring JM, Hochberg EP (2007) Primary CNS lymphoma. Nat Clin Pract Neurol 3:24–35PubMedCrossRefGoogle Scholar
  24. 24.
    Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 189–236Google Scholar
  25. 25.
    Kaluza V, Rao DS, Said JW, de Vos S (2006) Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report. Hum Pathol 37:769–772PubMedCrossRefGoogle Scholar
  26. 26.
    Kim EY, Kim SS (2005) Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol 46:187–192PubMedCrossRefGoogle Scholar
  27. 27.
    Kitajima M, Korogi Y, Shigematsu Y, Liang L, Matsuoka M, Yamamoto T, Jhono M, Eto K, Takahashi M (2002) Central nervous system lesions in adult T-cell leukaemia: MRI and pathology. Neuroradiology 44:559–567PubMedCrossRefGoogle Scholar
  28. 28.
    Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59:1557–1562PubMedGoogle Scholar
  29. 29.
    Langerak AW, Molina TJ, Lavender FL, Pearson D, Flohr T, Sambade C, Schuuring E, Al Saati T, van Dongen JJ, van Krieken JH (2007) Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 concerted action BMH4-CT98–3936. Leukemia 21:222–229PubMedCrossRefGoogle Scholar
  30. 30.
    Li Y, Braylan RC, Al-Quran SZ (2007) Flow-cytometric assessment of T-cell clonality in clinical specimens. Labmedicine 38:477–482Google Scholar
  31. 31.
    Liapatas S, Nakou M, Rontogianni D (2003) Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 36:464–471PubMedCrossRefGoogle Scholar
  32. 32.
    Lin WL, Fincke JE, Sharer LR, Monos DS, Lu S, Gaughan J, Platsoucas CD, Oleszak EL (2005) Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts. Clin Exp Immunol 141:338–356PubMedCrossRefGoogle Scholar
  33. 33.
    Lister A, Abrey LE, Sandlund JT (2002) Central nervous system lymphoma. Hematology Am Soc Hematol Educ Program 283–296Google Scholar
  34. 34.
    Liu D, Schelper RL, Carter DA, Poiesz BJ, Shrimpton AE, Frankel BM, Hutchison RE (2003) Primary central nervous system cytotoxic/suppressor T-cell lymphoma: report of a unique case and review of the literature. Am J Surg Pathol 27:682–688PubMedCrossRefGoogle Scholar
  35. 35.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO Classification of tumours of the nervous system. IARC, Lyon, pp 187–192Google Scholar
  36. 36.
    Marshall AG, Pawson R, Thom M, Schulz TF, Scaravilli F, Rudge P (1998) HTLV-I associated primary CNS T-cell lymphoma. J Neurol Sci 158:226–231PubMedCrossRefGoogle Scholar
  37. 37.
    McDole J, Johnson AJ, Pirko I (2006) The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol Res 28:256–261PubMedCrossRefGoogle Scholar
  38. 38.
    Mohrmann RL, Arber DA (2000) CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin’s disease and review of the literature. Mod Pathol 13:1244–1252PubMedCrossRefGoogle Scholar
  39. 39.
    Rao DS, Said JW (2007) Small lymphoid proliferations in extranodal locations. Arch Pathol Lab Med 131:383–396PubMedGoogle Scholar
  40. 40.
    Sen F, Rassidakis GZ, Jones D, Medeiros LJ (2002) Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. Mod Pathol 15:625–631PubMedCrossRefGoogle Scholar
  41. 41.
    Shenkier TN, Blay JY, O’Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O’Brien P, Rubenstein J, Connors JM (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23:2233–2239PubMedCrossRefGoogle Scholar
  42. 42.
    Shenkier TN (2005) Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:651–664PubMedCrossRefGoogle Scholar
  43. 43.
    Stark AM, Tiemann M, Dorner L, Melnikowa E, Mehdorn HM, Blomer U (2004) Primary peripheral T-cell lymphoma of the central nervous system. Zentralbl Neurochir 65:191–194PubMedCrossRefGoogle Scholar
  44. 44.
    Su IC, Lien HC, Chen CM (2006) Primary brain T-cell lymphoma after kidney transplantation: a case report. Surg Neurol 66(Suppl 2):S60–S63PubMedCrossRefGoogle Scholar
  45. 45.
    Sun T, Akalin A, Rodacker M, Braun T (2004) CD20 positive T cell lymphoma: is it a real entity? J Clin Pathol 57:442–444PubMedCrossRefGoogle Scholar
  46. 46.
    Tan BT, Warnke RA, Arber DA (2006) The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 8:466–475PubMedCrossRefGoogle Scholar
  47. 47.
    Theriault C, Galoin S, Valmary S, Selves J, Lamant L, Roda D, Rigal-Huguet F, Brousset P, Delsol G, Al Saati T (2000) PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 13:1269–1279PubMedCrossRefGoogle Scholar
  48. 48.
    Van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH-CT98–3936. Leukemia 17:2257–2317PubMedCrossRefGoogle Scholar
  49. 49.
    Warnke RA, Jones D, Hsi ED (2007) Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. Am J Clin Pathol 127:511–527PubMedGoogle Scholar
  50. 50.
    Weller M (1999) Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 43:237–239PubMedCrossRefGoogle Scholar
  51. 51.
    Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri SA (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472–2479PubMedCrossRefGoogle Scholar
  52. 52.
    Yokose N, Ogata K, Sugisaki Y, Mori S, Yamada T, An E, Dan K (2001) CD20-positive T cell leukemia/lymphoma: case report and review of the literature. Ann Hematol 80:372–375PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Mohanpal Singh Dulai
    • 1
  • Christopher Y. Park
    • 1
  • William D. Howell
    • 1
  • Lawrence T. Smyth
    • 2
  • Mayuri Desai
    • 2
  • Diane M. Carter
    • 2
  • Hannes Vogel
    • 1
  1. 1.Department of PathologyStanford University Medical CenterStanfordUSA
  2. 2.Department of PathologyKaiser Permanente Medical CenterRedwood CityUSA

Personalised recommendations